[Pharmacokinetics of intravenous rifampicin (RMP) and its clinical evaluation in purulent bacterial meningitis]

Minerva Med. 1981 Apr 7;72(14):875-92.
[Article in Italian]

Abstract

A combined kinetic and clinical study showed that rifampicin displays good tissue diffusibility, though it may have a tendency to accumulate. A liquor transfer sufficient for the bacteria most commonly responsible for meningeal inflammation was observed; 15/18 cases of purulent bacterial meningitis treated were clinically cured without sequelae, while 1 displayed considerable improvement. Two patients died from unforseen, uncontrollable complications that were not related to administration of the drug.

Publication types

  • English Abstract

MeSH terms

  • Adolescent
  • Adult
  • Bacterial Infections / drug therapy*
  • Child
  • Drug Evaluation
  • Female
  • Humans
  • Infusions, Parenteral
  • Kinetics
  • Male
  • Meningitis / drug therapy*
  • Microbial Sensitivity Tests
  • Middle Aged
  • Rifampin / administration & dosage
  • Rifampin / cerebrospinal fluid
  • Rifampin / metabolism*
  • Rifampin / therapeutic use
  • Tissue Distribution

Substances

  • Rifampin